Inozyme Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inozyme Pharma to Present at the Jefferies Global Healthcare Conference

Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesInozyme pharmaMatt peraStefan rileyDoug trecoInozyme pharma incCorporate communicationsCompany or inozymeGlobenewswire incGlobal healthcare conferenceInvestor relationsSenior director

Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom

BOSTON, May 23, 2024 (GLOBE NEWSWIRE)

United statesPseudoxanthoma elasticumStefan rileyYves sabbaghMatt peraInozyme pharmaKurt gunterEndocrine society annual meetingExchange commissionEuropean calcified tissue society congressCorporate communicationsCompany or inozymeBoston convention exhibition centerInozyme pharma incClinical public healthMineral metabolism biomarkers

INZY Stock Earnings: Inozyme Pharma Misses EPS for Q1 2024

INZY Stock Earnings: Inozyme Pharma Misses EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Inozyme pharmaPlace earnings

Inozyme Pharma (NASDAQ:INZY) Given Outperform Rating at Wedbush

Wedbush restated their outperform rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a report issued on Monday, RTT News reports. Wedbush currently has a $15.00 price objective on the stock. Separately, HC Wainwright restated a buy rating and set a $16.00 target price on shares of Inozyme Pharma in a research note […]

Inozyme pharmaDouglasa trecoSchonfeld strategic advisorsSecurities exchange commissionInozyme pharma incInozyme pharma company profileEventide asset managementFree reportGet free reportExchange commissionCapital partnersStrategic advisorsCapital managementAsset managementInozyme pharma dailyNasdaq inzy

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday s Mid-Day Session - Tilray Brands (NASDAQ:TLRY)

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

United statesMicrostrategy incorporatedInozyme pharmaPiper sandlerDevin ryanNeogen corporationTuanche limitedPamelaj mcginnisPhotonics corporationNiu technologiesModerna incHanryu holdings incInozyme pharma incTilray brands incVincerx pharma incInmode ltd